Candriam Equities L Biotechnology Class S Unhedged Fonds
466.397,00
JPY
+9508,00
JPY
+2,08
%
NAV
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 6,09% |
| Gilead Sciences Inc | US3755581036 | 4,32% |
| Amgen Inc | US0311621009 | 4,02% |
| Vertex Pharmaceuticals Inc | US92532F1003 | 3,97% |
| Insmed Inc | US4576693075 | 3,73% |
| Regeneron Pharmaceuticals Inc | US75886F1075 | 3,52% |
| United Therapeutics Corp | US91307C1027 | 2,95% |
| BeOne Medicines Ltd ADR | US07725L1026 | 2,69% |
| Ionis Pharmaceuticals Inc | US4622221004 | 2,54% |
| Neurocrine Biosciences Inc | US64125C1099 | 2,53% |
| Sonstige | 63,65% |